Phase 1b/2 Study of Escalating Doses of the NEDD8 Activating Enzyme Inhibitor Pevonedistat Administered in Combination with Standard Induction Therapy (Cytarabine and Idarubicin) in Newly Diagnosed High Risk Acute Myeloid Leukemia

Carissa M. Feliciano, Kevin R. Kelly, Hetty E. Carraway et al.|Blood|2023

Cited by 0